论文部分内容阅读
目的:分析探讨子宫内膜异位症采用不同剂量米非司酮治疗的临床疗效。方法:选取80例子宫异位症患者作为研究对象,按照患者就诊顺序编号将其随机分为A组与B组,每组40例,A组行小剂量米非司酮治疗,B组行大剂量米非司酮治疗,总结两组治疗有效性与安全性。结果:A组治疗总有效率为95.0%,B组治疗总有效率为95.0%,A组治疗效果与B组相比无差异显著(P>0.05);A组恶心、潮热、多汗等不良反应发生率明显低于B组(P<0.05)。结论:子宫内膜异位症采用小剂量米非司酮治疗与大剂量药物治疗疗效相近,但是小剂量米非司酮治疗不良反应少,安全性高,值得推广应用。
Objective: To investigate the clinical efficacy of different doses of mifepristone in the treatment of endometriosis. Methods: Eighty patients with uterine atherosclerosis were selected as study subjects. Patients were randomly divided into group A and group B, 40 cases in each group. Group A received low-dose mifepristone treatment and group B Dose mifepristone treatment, summarize the effectiveness and safety of two groups. Results: The total effective rate of group A was 95.0%, and the total effective rate of group B was 95.0%. There was no significant difference between group A and group B (P> 0.05). In group A, nausea, hot flashes, hyperhidrosis The incidence of adverse reactions was significantly lower than that in group B (P <0.05). Conclusion: Endometriosis with low dose of mifepristone treatment is similar to the effect of high dose of drug treatment, but low dose of mifepristone treatment of adverse reactions, high safety, it is worth promoting the application.